Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?


If you aren't familiar with the Danish pharmaceutical company Novo Nordisk (NYSE: NVO), I bet you've seen commercials for its flagship medications Ozempic, Rybelsus, and Wegovy.

Indeed, the diabetes and obesity-care markets are scorching hot -- and Novo Nordisk is leading the charge thanks to its breakthrough treatments. 2023 was a milestone year for the company, and investors sent shares soaring by 53%.

But even after such a significant run-up in the stock, the momentum doesn't appear to be slowing down -- shares of Novo Nordisk are up 27% so far this year. With the stock hovering around all-time highs, surely some investors might be considering taking some profits.

Continue reading


Source Fool.com

Like: 0
NVO
Share

Comments